These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30598380)

  • 1. A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.
    Ortoleva JP; Cobey FC
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1310-1314. PubMed ID: 30598380
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.
    Woehlck HJ; Boettcher BT; Lauer KK; Cronin DC; Hong JC; Zimmerman MA; Kim J; Selim M
    A A Case Rep; 2016 Dec; 7(12):247-250. PubMed ID: 27749291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
    Cai Y; Mack A; Ladlie BL; Martin AK
    Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue is not a pure vasoconstrictor drug.
    Evora PR
    Ann Card Anaesth; 2016; 19(2):340-1. PubMed ID: 27052080
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.
    Shapeton AD; Mahmood F; Ortoleva JP
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):894-901. PubMed ID: 30217583
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
    Ortoleva J; Shapeton A; Vanneman M; Dalia AA
    J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement.
    Raikhelkar JK; Weiss AJ; Maysick L; Scurlock C
    J Cardiothorac Vasc Anesth; 2012 Oct; 26(5):878-9. PubMed ID: 21641821
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
    Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
    Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.
    Weinberg D; Running K; Kalarickal PL; Patel GP
    Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.
    Burnes ML; Boettcher BT; Woehlck HJ; Zundel MT; Iqbal Z; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):1012-1014. PubMed ID: 27838199
    [No Abstract]   [Full Text] [Related]  

  • 13. When the pressure drops: A case of vasoplegia during a structural heart intervention.
    Cox J; Noveras J; Harrell T; Nayak KR
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):280-284. PubMed ID: 31025531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.
    Zundel MT; Feih JT; Rinka JRG; Boettcher BT; Freed JK; Kaiser M; Ghadiali HY; Tawil JN; Woehlck HJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):452-457. PubMed ID: 28778773
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
    Smith BB; Warner MA; Armour S; Ritter MJ
    Ann Thorac Surg; 2019 Jan; 107(1):e57. PubMed ID: 30248323
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.
    Fischer GW; Bengtsson Y; Scarola S; Cohen E
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):463-6. PubMed ID: 18835528
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort.
    Furnish C; Mueller SW; Kiser TH; Dufficy L; Sullivan B; Beyer JT
    J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1763-1770. PubMed ID: 32115360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment.
    Omar S; Zedan A; Nugent K
    Am J Med Sci; 2015 Jan; 349(1):80-8. PubMed ID: 25247756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
    Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
    J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.